FDA 483 - AgileMD, Inc. - June 20, 2024

The provided document is a Premarket Notification 510(k) Review for AgileMD, Inc.'s eCARTv5 Clinical Deterioration Suite. The reviewer recommended that the device is Substantially Equivalent (SESE). This document does not contain any FDA Form 483 inspectional observations.